vs
biote Corp.（BTMD）与Niagen Bioscience, Inc.（NAGE）财务数据对比。点击上方公司名可切换其他公司
biote Corp.的季度营收约是Niagen Bioscience, Inc.的1.4倍（$46.4M vs $33.8M）。Niagen Bioscience, Inc.净利率更高（12.2% vs 4.2%，领先8.0%）。Niagen Bioscience, Inc.同比增速更快（16.2% vs -6.9%）。过去两年Niagen Bioscience, Inc.的营收复合增速更高（23.6% vs -0.4%）
biote Corp是一家专注于个性化生物同质性激素替代疗法的医疗企业，主要面向美国市场运营，为持牌医疗从业者提供相关培训课程，同时推出配套健康补剂与诊断服务，以提升患者诊疗效果。
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
BTMD vs NAGE — 直观对比
营收规模更大
BTMD
是对方的1.4倍
$33.8M
营收增速更快
NAGE
高出23.1%
-6.9%
净利率更高
NAGE
高出8.0%
4.2%
两年增速更快
NAGE
近两年复合增速
-0.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $46.4M | $33.8M |
| 净利润 | $2.0M | $4.1M |
| 毛利率 | — | 64.1% |
| 营业利润率 | 14.7% | 12.1% |
| 净利率 | 4.2% | 12.2% |
| 营收同比 | -6.9% | 16.2% |
| 净利润同比 | -47.2% | -42.4% |
| 每股收益（稀释后） | $0.05 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BTMDNAGE
| Q4 25 | $46.4M | $33.8M | ||
| Q3 25 | $48.0M | $34.0M | ||
| Q2 25 | $48.9M | $31.1M | ||
| Q1 25 | $49.0M | $30.5M | ||
| Q4 24 | $49.8M | $29.1M | ||
| Q3 24 | $51.4M | $25.6M | ||
| Q2 24 | $49.2M | $22.7M | ||
| Q1 24 | $46.8M | $22.2M |
净利润BTMDNAGE
| Q4 25 | $2.0M | $4.1M | ||
| Q3 25 | $8.2M | $4.6M | ||
| Q2 25 | $3.2M | $3.6M | ||
| Q1 25 | $13.7M | $5.1M | ||
| Q4 24 | $3.7M | $7.2M | ||
| Q3 24 | $10.7M | $1.9M | ||
| Q2 24 | $-7.1M | $-15.0K | ||
| Q1 24 | $-4.2M | $-492.0K |
毛利率BTMDNAGE
| Q4 25 | — | 64.1% | ||
| Q3 25 | — | 64.5% | ||
| Q2 25 | — | 65.0% | ||
| Q1 25 | — | 63.4% | ||
| Q4 24 | — | 62.5% | ||
| Q3 24 | — | 63.5% | ||
| Q2 24 | — | 60.2% | ||
| Q1 24 | — | 60.7% |
营业利润率BTMDNAGE
| Q4 25 | 14.7% | 12.1% | ||
| Q3 25 | 17.2% | 12.5% | ||
| Q2 25 | 22.0% | 10.2% | ||
| Q1 25 | 19.8% | 15.7% | ||
| Q4 24 | 5.6% | 24.4% | ||
| Q3 24 | 23.7% | 6.3% | ||
| Q2 24 | 12.7% | -1.1% | ||
| Q1 24 | 22.3% | -3.3% |
净利率BTMDNAGE
| Q4 25 | 4.2% | 12.2% | ||
| Q3 25 | 17.1% | 13.5% | ||
| Q2 25 | 6.5% | 11.6% | ||
| Q1 25 | 28.0% | 16.6% | ||
| Q4 24 | 7.4% | 24.6% | ||
| Q3 24 | 20.8% | 7.3% | ||
| Q2 24 | -14.4% | -0.1% | ||
| Q1 24 | -8.9% | -2.2% |
每股收益（稀释后）BTMDNAGE
| Q4 25 | $0.05 | $0.05 | ||
| Q3 25 | $0.22 | $0.05 | ||
| Q2 25 | $0.10 | $0.04 | ||
| Q1 25 | $0.37 | $0.06 | ||
| Q4 24 | $0.09 | $0.10 | ||
| Q3 24 | $0.33 | $0.02 | ||
| Q2 24 | $-0.21 | $0.00 | ||
| Q1 24 | $-0.12 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.1M | — |
| 总债务越低越好 | $103.1M | — |
| 股东权益账面价值 | $-58.5M | $76.5M |
| 总资产 | $107.6M | $106.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BTMDNAGE
| Q4 25 | $24.1M | — | ||
| Q3 25 | $28.0M | $64.1M | ||
| Q2 25 | $19.6M | $60.3M | ||
| Q1 25 | $41.7M | $55.5M | ||
| Q4 24 | $39.3M | $44.5M | ||
| Q3 24 | $38.2M | $32.2M | ||
| Q2 24 | $26.4M | $27.7M | ||
| Q1 24 | $78.8M | $27.4M |
总债务BTMDNAGE
| Q4 25 | $103.1M | — | ||
| Q3 25 | $104.7M | — | ||
| Q2 25 | $106.3M | — | ||
| Q1 25 | $107.8M | — | ||
| Q4 24 | $109.4M | — | ||
| Q3 24 | $110.9M | — | ||
| Q2 24 | $112.5M | — | ||
| Q1 24 | $114.1M | — |
股东权益BTMDNAGE
| Q4 25 | $-58.5M | $76.5M | ||
| Q3 25 | $-72.8M | $70.7M | ||
| Q2 25 | $-85.1M | $64.2M | ||
| Q1 25 | $-90.0M | $55.3M | ||
| Q4 24 | $-105.9M | $46.1M | ||
| Q3 24 | $-130.3M | $34.4M | ||
| Q2 24 | $-143.2M | $30.7M | ||
| Q1 24 | $-36.0M | $29.0M |
总资产BTMDNAGE
| Q4 25 | $107.6M | $106.4M | ||
| Q3 25 | $111.3M | $98.1M | ||
| Q2 25 | $104.8M | $91.5M | ||
| Q1 25 | $123.4M | $81.3M | ||
| Q4 24 | $122.4M | $68.3M | ||
| Q3 24 | $101.3M | $56.5M | ||
| Q2 24 | $92.9M | $54.0M | ||
| Q1 24 | $160.1M | $54.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.6M | $679.0K |
| 自由现金流经营现金流 - 资本支出 | $6.5M | — |
| 自由现金流率自由现金流/营收 | 14.0% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | 3.87× | 0.16× |
| 过去12个月自由现金流最近4个季度 | $30.2M | — |
8季度趋势，按日历期对齐
经营现金流BTMDNAGE
| Q4 25 | $7.6M | $679.0K | ||
| Q3 25 | $14.1M | $3.7M | ||
| Q2 25 | $7.1M | $1.3M | ||
| Q1 25 | $6.5M | $7.9M | ||
| Q4 24 | $12.4M | $8.6M | ||
| Q3 24 | $15.6M | $3.5M | ||
| Q2 24 | $9.9M | $-264.0K | ||
| Q1 24 | $7.4M | $295.0K |
自由现金流BTMDNAGE
| Q4 25 | $6.5M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $4.8M | — | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $14.0M | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $6.7M | — |
自由现金流率BTMDNAGE
| Q4 25 | 14.0% | — | ||
| Q3 25 | 28.3% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 27.3% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 14.2% | — |
资本支出强度BTMDNAGE
| Q4 25 | 2.3% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 1.5% | — |
现金转化率BTMDNAGE
| Q4 25 | 3.87× | 0.16× | ||
| Q3 25 | 1.72× | 0.81× | ||
| Q2 25 | 2.22× | 0.35× | ||
| Q1 25 | 0.47× | 1.56× | ||
| Q4 24 | 3.34× | 1.20× | ||
| Q3 24 | 1.45× | 1.86× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BTMD
| Product Revenue | $45.3M | 98% |
| Disposable Trocars Product Revenue | $1.2M | 3% |
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
